KDEVF
Price:
$0.2576
Market Cap:
$75.73M
Karolinska Development AB (publ) operates as a venture capital firm, primarily focused on providing funding to nascent companies across seed, early, and growth stages. Its investment strategy targets a wide array of life science domains, including pharmaceutical and genetic research and development, medical advancements, healthcare technology, innovative drug delivery systems, biotechnology, and specialized tools and service providers for the life science industry. The company strategically prioritizes investment opportunities within the Nordic region, specifically highlighting Sweden, Iceland, Norway, Finland, and Denmark. While the firm prefers to assume the role of a lead investor in its ...[Read more]
Industry
Biotechnology
IPO Date
2019-04-05
Stock Exchange
OTC
Ticker
KDEVF
According to Karolinska Development AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -6.44. This represents a change of 631.20% compared to the average of -0.88 of the last 4 quarters.
The mean historical PE Ratio of Karolinska Development AB (publ) over the last ten years is 6.77. The current -6.44 PE Ratio has changed -9611.19% with respect to the historical average. Over the past ten years (40 quarters), KDEVF's PE Ratio was at its highest in in the March 2024 quarter at 492.96. The PE Ratio was at its lowest in in the September 2021 quarter at -137.25.
Average
6.77
Median
-0.08
Minimum
-31.74
Maximum
85.17
Discovering the peaks and valleys of Karolinska Development AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 541.11%
Maximum Annual PE Ratio = 85.17
Minimum Annual Increase = -2873.80%
Minimum Annual PE Ratio = -31.74
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.61 | -98.09% |
| 2024 | -31.74 | -137.27% |
| 2023 | 85.17 | -2873.80% |
| 2022 | -3.07 | -203.09% |
| 2021 | 2.98 | -421.97% |
| 2020 | -0.93 | -306.60% |
| 2019 | 0.45 | -96.98% |
| 2018 | 14.81 | 541.11% |
| 2017 | 2.31 | -238.96% |
| 2016 | -1.66 | 204.34% |
The current PE Ratio of Karolinska Development AB (publ) (KDEVF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
17.61
5-year avg
10.55
10-year avg
6.77
Karolinska Development AB (publ)’s PE Ratio is less than E-therapeutics Plc (-4.71), less than Biostage, Inc. (-2.79), less than Oncopeptides AB (publ) (-2.15), greater than Herantis Pharma Oyj (-7.00), less than Medivir AB (publ) (-4.51), less than SymBio Pharmaceuticals Limited (-0.80), less than Mindset Pharma Inc. (-4.01), less than Ecofibre Limited (-0.16), less than Abliva AB (publ) (-4.91), less than Kiaro Holdings Corp. (0),
| Company | PE Ratio | Market cap |
|---|---|---|
| -4.71 | $75.96M | |
| -2.79 | $57.82M | |
| -2.15 | $55.98M | |
| -7.00 | $59.47M | |
| -4.51 | $45.78M | |
| -0.80 | $26.38M | |
| -4.01 | $54.51M | |
| -0.16 | $73.67M | |
| -4.91 | $45.13M | |
| 0 | $442.00 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Karolinska Development AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Karolinska Development AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Karolinska Development AB (publ)'s PE Ratio?
How is the PE Ratio calculated for Karolinska Development AB (publ) (KDEVF)?
What is the highest PE Ratio for Karolinska Development AB (publ) (KDEVF)?
What is the 3-year average PE Ratio for Karolinska Development AB (publ) (KDEVF)?
What is the 5-year average PE Ratio for Karolinska Development AB (publ) (KDEVF)?
How does the current PE Ratio for Karolinska Development AB (publ) (KDEVF) compare to its historical average?